Medtronic plc — Director's Dealing 2020

Oct 9, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2020-10-08

Reporting Person: Lerman Bradley E (SVP General Counsel & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-08	Ordinary Shares	M	19917	$62.76	Acquired	74242	Direct
2020-10-08	Ordinary Shares	S	19917	$110.00	Disposed	54325	Direct
2020-10-08	Ordinary Shares	M	797	$62.76	Acquired	55122	Direct
2020-10-08	Ordinary Shares	S	797	$110.00	Disposed	54325	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-08	Stock Option (Right to Buy)	$62.76	M	19917	Disposed	2024-07-28	Ordinary Shares (19917)	Direct
2020-10-08	Stock Option (Right to Buy)	$62.76	M	797	Disposed	2024-07-28	Ordinary Shares (797)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This option to purchase 39,835 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 39,835 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F3: This option become exercisable on June 29, 2018, subject to New Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018."